Evaluation of Parathyroid in Patients with Nephrolithiasis
In patients with nephrolithiasis, measure serum calcium levels, and if elevated (≥10.2 mg/dL), proceed immediately with parathyroid hormone (PTH) measurement to diagnose primary hyperparathyroidism (PHPT), which affects approximately 5-7% of kidney stone patients and is a surgically curable cause of recurrent stones.
Biochemical Evaluation Algorithm
The evaluation should follow this stepwise approach:
Step 1: Measure Serum Calcium
- Check serum calcium in all patients presenting with nephrolithiasis 1, 2, 3
- Repeat calcium measurements at least three times if initial values are borderline, as hypercalcemia can be discrete or intermittent 4
- Consider measuring ionized calcium to improve detection of hypercalcemia 4
- Hypercalcemia is defined as ≥10.2 mg/dL 1
Step 2: Measure PTH if Hypercalcemic
- If calcium is elevated, immediately measure intact PTH (1-84 PTH) 5, 4
- Do not delay—studies show mean elapsed time from presentation to PTH measurement averages 183 days, which is unacceptably long 3
- PTH >64 pg/mL is elevated; PTH 40-64 pg/mL is non-suppressed and inappropriate in the setting of hypercalcemia 1
Step 3: Interpret Results
PHPT is diagnosed when:
- Hypercalcemia is present AND
- PTH is either elevated (>64 pg/mL) OR inappropriately normal/non-suppressed (40-64 pg/mL) in the context of hypercalcemia 1, 4
A PTH value in the "normal range" but not suppressed in the presence of hypercalcemia is sufficient for PHPT diagnosis 4.
Clinical Context and Diagnostic Yield
The evidence reveals significant underdiagnosis:
- Only 64% of nephrolithiasis patients have calcium measured 3
- Among hypercalcemic patients, only 13.6-27.9% have PTH measured 1, 2
- PTH has 89% diagnostic sensitivity for PHPT in nephrolithiasis patients 5
- Among those with PTH measured, 63.6% have elevated or non-suppressed PTH 1
Additional Metabolic Markers
While PTH measurement is the cornerstone, other markers have lower diagnostic utility:
- Cyclic AMP (cAMP): Elevated in 68% of PHPT patients but only 12% sensitive 5
- Calcium load test: Positive in 81% but less practical 5
- Bone density: Often low in PHPT and helps support diagnosis 5
Critical Pitfalls to Avoid
Single calcium measurement: Hypercalcemia may be intermittent—repeat testing is essential 4
Dismissing "normal" PTH: A PTH in the normal reference range is inappropriate when calcium is elevated and indicates PHPT 4
Delayed PTH measurement: Current practice shows unacceptable delays averaging 6 months 3. Implement reflex testing or electronic health record alerts to trigger automatic PTH measurement when calcium is elevated 3
Failure to refer: Only 19.6-45.6% of diagnosed PHPT patients receive specialist referral 1, 2. All patients with confirmed PHPT should be referred to endocrine surgery for evaluation, as parathyroidectomy is curative 6
Assay Considerations
Be aware that different PTH assay generations (second vs. third generation) measure PTH fragments differently 7. However, for classic PHPT diagnosis in nephrolithiasis patients, the type of PTH assay used will not affect diagnosis or management because the precise PTH concentration is less relevant than the pattern of elevated/non-suppressed PTH with hypercalcemia 7.
Imaging Considerations
Imaging has no utility in confirming or excluding the diagnosis of PHPT 6. Parathyroid imaging (ultrasound, sestamibi scan, or 4D-CT) is reserved for preoperative localization once the biochemical diagnosis is established and surgery is planned 6.